Have you or your loved ones been diagnosed with chronic obstructive pulmonary disease (copd)?

You may be eligible to participate in a chronic obstructive pulmonary disease (copd) clinical trial.

Have you or your loved ones been diagnosed with chronic obstructive pulmonary disease (copd)? You may be eligible to participate in a chronic obstructive pulmonary disease (copd) clinical trial.

What is a clinical trial? Is participating in a clinical trial right for you? Learn more

Recruiting for this study? Get access to patient recruitment tools.
Chronic Obstructive Pulmonary Disease (COPD) Clinical Trial in Calgary Alberta
NCT02398643 | Interventional

Have you or your loved ones been diagnosed with chronic obstructive pulmonary disease (copd)?

You may be eligible to participate in a chronic obstructive pulmonary disease (copd) clinical trial.

Have you or your loved ones been diagnosed with chronic obstructive pulmonary disease (copd)? You may be eligible to participate in a chronic obstructive pulmonary disease (copd) clinical trial.

Recruiting

Male & Female

50 - 85

Years old

This study is looking to recruit 150 Participants

Chronic obstructive pulmonary disease (COPD) is a chronic lung disease primarily caused by smoking. COPD creates a tremendous burden to the healthcare system, as disease exacerbations result in frequent, prolonged hospitalizations. While originally considered a disease specific to the lung, data has shown that COPD is associated with substantial cardiovascular (CV) morbidity and mortality. Exacerbations of COPD requiring hospitalization result in marked patient deterioration, and heightened CV risk. The cause of the increased CV risk with stable COPD, and the exaggerated CV risk during exacerbations of the disease are unknown; however, it may be due to chronic inflammation which is exacerbated with a flare-up of the disease, and/or chronic inactivity which is similarly worsened with bed-rest during a hospitalization. Despite the impact of COPD on healthcare, there are relatively few studies examining how COPD inpatient care impacts on patient outcomes, inflammation and CV risk. Disease management programs, such as pulmonary rehabilitation and patient self-management education, are part of guideline therapy for COPD; however, these are not regularly implemented following a hospitalization, and how these interventions affect patient outcomes, behavior, physical activity, inflammation and CV risk have not been well studied. The proposed long-term project will examine how early referral to chronic disease management programs after hospital discharge, affect patient outcomes. This study will provide invaluable information about outpatient management for a disease which has a tremendous impact on healthcare.

Where you'll go

Selected location

University of Calgary

University of Calgary Change

2500 University Drive Northwest, Calgary, Alberta, CAN T2N4Z6

Brandie Walker, MD, PhD 403-220-4135
blthorla@ucalgary.ca

Map | Learn more
Interested in learning more?
Selected location

University of Calgary

2500 University Drive Northwest, Calgary, Alberta, CAN T2N4Z6

Brandie Walker, MD, PhD 403-220-4135
blthorla@ucalgary.ca


The information you provide is confidential and is never sold or shared with outside vendors. By clicking the button, you agree to the PatientWing's Terms and Privacy Policy.